Latest filing published 15 Nov 2021 for Hansa Biopharma AB, €19k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Vincenza Nigro: trading record in brief
Vincenza Nigro is a declared insider of Hansa Biopharma AB, with filings sourced from Finansinspektionen. We count 2 filings; the first trade dates from 17 December 2019 and the latest from 9 November 2021.
No open-market sale appears; the market trades are 2 purchases worth €39k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2021: 1 purchase and no sales on the market.
The record was last updated on 15 November 2021 with an open-market purchase (€19k) in Hansa Biopharma AB. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Companies and markets linked to Vincenza Nigro
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,000 shares@ SEK 92.4048.1% of flowAktieISIN SE0002148817FI:csv-1f74f743ffdafd1b8872Canonical exit: 7 Feb 2022 (T+90)
- 3,000 shares@ SEK 69.75100.0% of flowAktieISIN SE0002148817FI:csv-e87e5c9c20c34baeba98Canonical exit: 16 Mar 2020 (T+90)
2 of 2 declarations